PAX5 and precursor B-cell acute lymphoblastic leukemia: Therefore, approaches that can by-pass the differentiation blockage resulting from PAX5 haploinsufficiency may lead to novel therapeutic approaches for this group of B-ALL, including but not limited to PAX5 restoration and PAX5 paralog activation.